Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
MIMS and Makati Medical Center Partner to Enhance Medication Adherence and Safety 2016-09-20 12:39
Jubilant Biosys Strengthens Its Leadership Team With Two Key Appointments 2016-09-19 22:11
Golden Meditech and MD Anderson Team Up to Create Cellenkos, Inc. 2016-09-19 08:55
Semaglutide Reduced Major Cardiovascular Events by 26% in Adults with Type 2 Diabetes at High Cardiovascular Risk 2016-09-18 11:22
Favorable Benefit: Risk Profile for Vedolizumab as Induction and Maintenance Therapy in TNF-Naïve or TNF-Failure Patients with Moderately to Severely Active Ulcerative Colitis Published in Clinical Gastroenterology and Hepatology 2016-09-18 10:54
Dr. Daniel Von Hoff, MD, F.A.C.P. Joins Athenex's Clinical Scientific Advisory Board 2016-09-18 09:25
Victoza(R) lowered the progression of kidney damage in adults with type 2 diabetes at high CV risk 2016-09-15 23:16
Toujeo(R) Demonstrates a More Stable Profile and Lower Within-day Variability Compared to Insulin Degludec 2016-09-15 20:15
Varian Selected to Provide Compact Single-room Proton Therapy System for New Oncology Center in Singapore 2016-09-14 20:15
Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes 2016-09-14 20:00
Saxenda(R) Provides Consistent Weight Loss and Improvements in Blood Glucose Control Across BMI Categories After Three Years of Treatment 2016-09-14 17:25
Conversion of Convertible Notes 2016-09-14 12:07
Frost & Sullivan Acknowledges the Role Played by Cell Science Systems' Alcat Test® for Food Intolerance in Keeping the Company at the Top of the Leaderboard 2016-09-13 20:00
Frost & Sullivan Commends Mobile Heartbeat(TM) for Standing Out with its Feature-rich Smartphone Application that Serves the Complete Communication Needs of Clinicians 2016-09-13 20:00
Semaglutide Demonstrated Superior HbA1c Reduction vs Placebo as Add-on to Basal Insulin Alone or with Metformin in Adults with type 2 Diabetes 2016-09-13 17:59
Adults with Type 2 Diabetes Treated with Xultophy(R) (IDegLira) were up to 4.5 Times More Likely to Reach Glycaemic Targets Without Hypoglycaemia and Weight Gain vs Up-titration with Insulin Glargine U100 2016-09-13 17:59
OGT Expands Cytocell FISH Probe Portfolio for Lung Cancers 2016-09-13 17:00
Merck's Consumer Health Business Presents New Purpose to Help Prepare Society for 100 Healthy Years 2016-09-13 15:17
Dr. Jean-Luc Lowinski, Sanofi Asia Senior Vice President and China President, Honored with 2016 Shanghai Magnolia Silver Award 2016-09-13 09:00
Merck Announces Recipients of the Grant for Growth Innovation 2016 2016-09-12 14:15
1 501 502 503 504 505 520